Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_1320
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 1320
Character Range: 627250–628896

1320                                      CETYLPYRIDINIUM CHLORIDE                                                                         A, E      Only permitted for use in medicines containing 5% or less of quaternary ammonium compounds.
                                                                                                                                                     When used as an excipient ingredient, only for use in topical medicines for dermal application.
                                                                                                                                                     When used as an active ingredient:
                                                                                                                                                     (a) permitted for use only in medicated throat lozenges;
                                                                                                                                                     (b) the medicine must not contain more than 2 milligrams of cetylpyridinium chloride per lozenge;
                                                                                                                                                     (c) the maximum recommended daily dose of the medicine must not provide more than 24 milligrams of cetylpyridinium chloride; and
                                                                                                                                                     (d) the medicine label must specify that the medicine is only to be used for 7 days (or less).